+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Allergy and Immunology Market, By Treatment Type, By Allergy Type, By Distribution Channel, By Region, Trend Analysis, Competitive Market Share & Forecast, 2017-2027

  • PDF Icon

    Report

  • 197 Pages
  • August 2021
  • Region: Global
  • Blueweave Consulting & Research Pvt Ltd
  • ID: 5457775

Global Allergy and Immunology Market Booming: Growing at a CAGR of 11.2% in the Forecast Period


The global allergy and immunology market is gaining traction due to a number of factors including a growing number of allergies, including food allergies, pollen allergies, and pet allergies. Moreover, research and development activities for investigating the causes and treatments of allergies is also favoring the market growth.

A recent study conducted revealed that the global allergy and immunology market was worth USD 2.1 billion in 2020. The market is estimated to grow at a CAGR of 11.2%, earning revenue of around USD 4.5 billion by the end of 2027. The global allergy and immunology market is growing at a rapid rate due to the increasing prevalence of allergies, such as food allergies, pollen allergies, pet allergies, etc., as well as growing research activities. The healthcare system is burdened with complex allergy problems, which drives R&D for the development of new medicines. However, the lack of awareness regarding allergy and immunology may act as a barrier to market growth.

Increasing Prevalence of Autoimmune Diseases is Boosting the Global Allergy & Immunology Market


It has been estimated that around 4% of the world’s population is affected by autoimmune diseases, among which type 1 diabetes, multiple sclerosis, lupus, etc., are very common. Scientists claim that with the growing prevalence of autoimmune diseases, the market for allergy and immunology will flourish in the near future. Additionally, with the increasing awareness regarding these conditions in developed and developing countries alike, along with increasing research efforts towards these health conditions, the global allergy & immunology market is projected to grow.

Availability of Wide Range of Allergy Treatment Drugs Is Driving the Growth of The Global Allergy & Immunology Market


The availability of a broad spectrum of allergy drugs is also influencing the growth of the global allergy & immunology market.The availability of various drugs such as monoclonal antibodies, fusion proteins, immunosuppressants, polyclonal antibodies, and others in pharmacies and online stores is influencing market growth significantly. Among these drugs, the demand for monoclonal antibodies is very prominent in the allergy & immunology market because of their high efficiency in the treatment of autoimmune diseases and other rare conditions.

Global Allergy & Immunology Market - By Distribution Channel


Based on distribution channels, the global allergy & immunology market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. Among these, the hospital pharmacy segment accounts for the largest market share because of the increasing patient pool approaching hospitals for the treatment of different types of allergies. Moreover, many allergy drugs and shots are available in hospital pharmacies upon prescription. However, online pharmacies are gaining traction, especially since the COVID-19 outbreak, as people nowadays prefer buying medications online rather than stepping outside of the home in order to adhere to social distancing. Pharmaceutical businesses make a variety of drugs available through online stores and websites, which can even be subscribed to.

Global Allergy & Immunology Market - Regional Insights


Geographically, the global allergy & immunology market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Among these regions, Europe accounts for the largest share in the market, followed by North America. The presence of a strong healthcare system and potentially high awareness regarding the presence of allergic treatments and immunology is propelling the growth of the allergy & immunology market in the European market. North America also covers a substantial market share and is expected to witness the highest CAGR because of the growing prevalence of food allergies and increasing research activities in immunology.

Impact of COVID-19 on Global Allergy & Immunology Market


One of the few markets that have been able to withstand the COVID-19 pandemic is the global allergy and immunology market. While the prevalence of allergic disorders increased during the quarantine period, the need for allergies treatment and drugs remained stable and even experienced a significant surge. Furthermore, pharmaceutical companies made their products and treatments available online and streamlined their distribution channels, making it easier for them to meet demand.

Competitive Landscape


The leading market players in the global allergy & immunology market are ALK-Abello A/S, Teva Pharmaceutical Industries, AbbVie Inc., Stallergenes Greer PLC, Allergy Therapeutics, Sanofi SA, Anacor Pharmaceuticals Inc., Novartis International AG, AstraZeneca, Merck KGaA, F. Hoffmann-La Roche Ltd, Leti Pharma, Galderma SA, Johnson & Johnson, GlaxoSmithKline PLC, Circassia, DESENTUM OY, HAL Allergy B.V., Mylan N.V., and other prominent players.

The global allergy & immunology market is highly consolidated with the presence of several global as well as regional industry players. Research and development activities are heavily intensive in this market. The market players consistently focus on launching a variety of products that target relief for various types of allergies.Furthermore, the adoption of competitive strategies like partnerships, mergers, collaborations, mergers & acquisitionsis also very prominent in this market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global allergy & immunology market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends of the global allergy & immunology market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.


This product will be delivered within 2 business days.

Table of Contents

1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Key Market Segments
2. Research Methodology
2.1. Qualitative Research
2.2. Methodology
2.3. Regional Split of Primary & Secondary Research
2.4. Secondary Research
2.5. Primary Research
2.5.1. Breakdown of Primary Research Respondents, By Region
2.5.2. Breakdown of Primary Research Respondents, By Industry Participants
2.6. Market Size Estimation
2.7. Assumptions for the Study
2.8. Market Breakdown & Data Triangulation
3. Executive Summary
4. Industry Insight and Growth Strategy
4.1. Value Chain Analysis
4.2. DROC Analysis
4.2.1. Market Drivers
4.2.1.1. Increasing Prevalence of Food Allergies In Developed Countries
4.2.1.2. Expanding Research and Development Activities Regarding Allergy and Immunology
4.2.2. Market Restraints
4.2.2.1. Lack of Awareness Towards Allergy and Immunotherapy
4.2.3. Market Challenges
4.2.3.1. High Cost of Allergy Treatment
4.2.4. Market Opportunity
4.2.4.1. Increasing Prevalence of Autoimmune diseases
4.2.4.2. Availability of Wide Range of Allergy Treatment Drugs
4.3. Recent Developments
4.4. Porter’s Five Forces Analysis
4.4.1. Bargaining Power of Buyers
4.4.2. Bargaining Power of Suppliers
4.4.3. Intensity of Rivalry
4.4.4. Threat of New Entrants
4.4.5. Threat of Substitutes
5. Global Allergy & Immunology Market Overview
5.1. Market Size & Forecast by Value, 2017-2027
5.2. Market Size and Forecast, By Segment
5.2.1. By Treatment Type
5.2.1.1. Subcutaneous Immunotherapy (SCIT)
5.2.1.2. Sublingual Immunotherapy (SLIT)
5.2.1.2.1. Tablets
5.2.1.2.2. Drops
5.2.2. By Allergy Type
5.2.2.1. Allergic Rhinitis
5.2.2.2. Allergic Asthma
5.2.2.3. Other Allergies
5.2.3. By Distribution Channel
5.2.3.1. Hospital Pharmacy
5.2.3.2. Retail Pharmacy
5.2.3.3. Online Pharmacy
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. The Asia-Pacific
5.2.4.4. Latin America
5.2.4.5. The Middle East &Africa
6. North America Allergy & Immunology Market Overview
6.1. Market Size and Forecast
6.1.1. By Value (USDBillion), 2020-2027
6.2. Market Share and Forecast
6.2.1. By Treatment Type
6.2.2. By Allergy Type
6.2.3. By Distribution Channel
6.2.4. By Country
6.2.4.1. U.S.
6.2.4.2. Canada
7. Europe Allergy & Immunology Market Overview
7.1. Market Size and Forecast
7.1.1. By Value (USDBillion), 2020-2027
7.2. Market Share and Forecast
7.2.1. By Treatment Type
7.2.2. By Allergy Type
7.2.3. By Distribution Channel
7.2.4. By Country
7.2.4.1. Germany
7.2.4.2. U.K.
7.2.4.3. Russia
7.2.4.4. France
7.2.4.5. Italy
7.2.4.6. Spain
7.2.4.7. Rest of Europe
8. APAC Allergy & Immunology Market Overview
8.1. Market Size and Forecast
8.1.1. By Value (USDBillion), 2020-2027
8.2. Market Share and Forecast
8.2.1. By Treatment Type
8.2.2. By Allergy Type
8.2.3. By Distribution Channel
8.2.4. By Country
8.2.4.1. China
8.2.4.2. India
8.2.4.3. Japan
8.2.4.4. South Korea
8.2.4.5. Rest of APAC
9. LATAM Allergy & Immunology Market Overview
9.1. Market Size and Forecast
9.1.1. By Value (USDBillion), 2020-2027
9.2. Market Share and Forecast
9.2.1. By Treatment Type
9.2.2. By Allergy Type
9.2.3. By Distribution Channel
9.2.4. By Country
9.2.4.1. Mexico
9.2.4.2. Brazil
9.2.4.3. Rest of LATAM
10. MEA Allergy & Immunology Market Overview
10.1. Market Size and Forecast
10.1.1. By Value (USDBillion), 2020-2027
10.2. Market Share and Forecast
10.3. By Treatment Type
10.4. By Allergy Type
10.5. By Distribution Channel
10.6. By Country
10.6.1. Saudi Arabia
10.6.2. UAE
10.6.3. South Africa
10.6.4. Rest of MEA
11. Competitive Landscape
11.1. List of Key Players and Their Offerings
11.2. Market Share Analysis (2020)
11.3. Competitive Benchmarking By Operating Parameters
12. Impact of COVID-19 on Global Allergy & Immunology Market
13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
13.1. ALK-Abello A/S
13.2. Teva Pharmaceutical Industries
13.3. AbbVie Inc.
13.4. Stallergenes Greer PLC
13.5. Allergy Therapeutics
13.6. Sanofi SA
13.7. Anacor Pharmaceuticals Inc.
13.8. Novartis International AG
13.9. AstraZeneca
13.10. Merck KGaA
13.11. F. Hoffmann-La Roche Ltd
13.12. Leti Pharma
13.13. Galderma SA
13.14. Johnson & Johnson
13.15. GlaxoSmithKline PLC
13.16. Circassia
13.17. DESENTUM OY
13.18. HAL Allergy B.V.
13.19. Mylan N.V.
13.20. Other Prominent Players
14. Key Strategic Recommendations
List of Figures
Figure 1: Global Allergy & Immunology Segmentation
Figure 2: Global Allergy & Immunology Market Value Chain Analysis,
Figure 3: Company Market Share Analysis, 2020
Figure 4: Global Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027
Figure 5: Global Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027
Figure 6: Global Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027
Figure 7: Global Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027
Figure 8: Global Allergy &Immunology Market Share (%), By Region, By Value, 2020-2027
Figure 9: North America Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027
Figure 10: North America Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027
Figure 11: North America Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027
Figure 12: North America Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027
Figure 13: North America Allergy & Immunology Market Share (%), By Country, By Value, 2020-2027
Figure 14: Europe Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027
Figure 15: Europe Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027
Figure 16: Europe Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027
Figure 17: Europe Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027
Figure 18: Europe Allergy & Immunology Market Share (%), By Country, By Value, 2020-2027
Figure 19: the Asia-Pacific Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027
Figure 20: the Asia-Pacific Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027
Figure 21: the Asia-Pacific Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027
Figure 22: the Asia-Pacific Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027
Figure 23: the Asia-Pacific Allergy & Immunology Market Share (%), By Country, By Value, 2020-2027
Figure 24: Latin America Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027
Figure 25: Latin America Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027
Figure 26: Latin America Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027
Figure 27: Latin America Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027
Figure 28: Latin America Allergy & Immunology Market Share (%), By Country, By Value, 2020-2027
Figure 29: Middle East & Africa Allergy & Immunology Market Size, By Value (USD Billion), 2020-2027
Figure 30: Middle East & Africa Allergy & Immunology Market Share (%), By Treatment Type, By Value, 2020-2027
Figure 31: Middle East & Africa Allergy & Immunology Market Share (%), By Allergy Type, By Value, 2020-2027
Figure 32: Middle East & Africa Allergy & Immunology Market Share (%), By Distribution Channel, By Value, 2020-2027
Figure33: Middle East & Africa Allergy & Immunology Market Share (%), By Region, By Value, 2020-2027
List of Tables
Table 1: Global Allergy & Immunology Market Size, By Treatment Type, By Value, 2020-2027
Table 2: Global Allergy & Immunology Market Size, By Allergy Type, By Value(USD Billion), 2020-2027
Table 3: Global Allergy & Immunology Market Size, By Distribution Channel, By Value(USD Billion), 2020-2027
Table 4: Global Allergy & Immunology Market Size, By Region, By Value(USD Billion), 2020-2027
Table 5: North America Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027
Table 6: North America Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027
Table 7: North America Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027
Table 8: North America Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027
Table 9: Europe Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027
Table 10: Europe Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027
Table 11: Europe Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027
Table 12: Europe Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027
Table 13: the Asia-Pacific Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027
Table 14: the Asia-Pacific Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027
Table 15: the Asia-Pacific Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027
Table 16: the Asia-Pacific Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027
Table 17: Latin America Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027
Table 18: Latin America Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027
Table 19: Latin America Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027
Table 20: Latin America Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027
Table 21: The Middle-East & Africa Allergy & Immunology Market Size, By Treatment Type, By Value (USD Billion), 2020-2027
Table 22: The Middle-East & Africa Allergy & Immunology Market Size, By Allergy Type, By Value (USD Billion), 2020-2027
Table 23: The Middle-East & Africa Allergy & Immunology Market Size, By Distribution Channel, By Value (USD Billion), 2020-2027
Table 24: The Middle-East & Africa Allergy & Immunology Market Size, By Country, By Value (USD Billion), 2020-2027
Table 25: ALK-Abello A/S Financial Analysis
Table 26: ALK-Abello A/S Business Overview
Table 27: Teva Pharmaceutical Industries Financial Analysis
Table 28: Teva Pharmaceutical IndustriesBusiness Overview
Table 29: AbbVie Inc. Corporation Financial Analysis
Table 30: AbbVie Inc. Corporation Business Overview
Table 31: Stallergenes Greer PLCFinancial Analysis
Table 32: Stallergenes Greer PLC Business Overview
Table 33: Allergy Therapeutics Financial Analysis
Table 34: Allergy Therapeutics Business Overview
Table 35: Sanofi SA Financial Analysis
Table 36: Sanofi SA Business Overview
Table 37: Anacor Pharmaceuticals Inc. Financial Analysis
Table 38: Anacor Pharmaceuticals Inc. Business Overview
Table 39: Novartis International AG Financial Analysis
Table 40:Novartis International AG Business Overview
Table 41: AstraZeneca Financial Analysis
Table 42: AstraZeneca Business Overview
Table 43: Merck KGaAFinancial Analysis
Table 44: Merck KGaA Business Overview
Table 45: F. Hoffmann-La Roche LtdFinancial Analysis
Table 46: F. Hoffmann-La Roche Ltd Financial Analysis
Table 47: Leti PharmaFinancial Analysis
Table 48: Leti Pharma Financial Analysis
Table 49: Galderma SA Financial Analysis
Table 50: Galderma SA Financial Analysis
Table 51: Johnson & JohnsonFinancial Analysis
Table 52: Johnson & Johnson Financial Analysis
Table 53: GlaxoSmithKline PLCFinancial Analysis
Table 54: GlaxoSmithKline PLC Financial Analysis
Table 55: CircassiaFinancial Analysis
Table 56: Circassia Financial Analysis
Table 57: DESENTUM OYFinancial Analysis
Table 58: DESENTUM OY Financial Analysis
Table 59: HAL Allergy B.V.Financial Analysis
Table 60: HAL Allergy B.V. Financial Analysis
Table 61: Mylan N.V.Financial Analysis
Table 62: Mylan N.V. Financial Analysis

Methodology

Loading
LOADING...